“Survival Rate of Gemcitabine Monotherapy after Prior Platinum-based Chemotherapy for Metastatic Bladder Cancer”. Cermin Dunia Kedokteran, vol. 49, no. 12, Desember 2022, hlm. 693-01, https://doi.org/10.55175/cdk.v49i12.329.